What is KeyCorp's Forecast for TriMas Q3 Earnings?

Key Points

• KeyCorp has issued a Q3 2025 earnings estimate for TriMas Corporation, projecting earnings of $0.57 per share, maintaining a "Strong-Buy" rating on the stock.
• TriMas reported a net margin of 3.83% and a return on equity of 11.49% in their last quarterly earnings, exceeding analysts' expectations with revenue of $274.76 million.
• Uniquely, TriMas insiders purchased a total of 848,232 shares worth approximately $21.6 million over the last quarter, indicating strong confidence in the company's future.

TriMas Corporation (NASDAQ:TRS - Free Report) - Research analysts at KeyCorp issued their Q3 2025 EPS estimates for TriMas in a note issued to investors on Tuesday, August 12th. KeyCorp analyst K. Newman forecasts that the industrial products company will post earnings of $0.57 per share for the quarter. KeyCorp currently has a "Overweight" rating and a $45.00 target price on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. KeyCorp also issued estimates for TriMas' FY2025 earnings at $2.09 EPS, Q2 2026 earnings at $0.73 EPS and Q3 2026 earnings at $0.67 EPS.

TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The industrial products company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.50 by $0.11. TriMas had a net margin of 3.83% and a return on equity of 11.49%. The firm had revenue of $274.76 million during the quarter, compared to analyst estimates of $251.18 million. During the same quarter in the prior year, the business posted $0.43 earnings per share. TriMas's revenue for the quarter was up 14.2% compared to the same quarter last year.

Several other equities analysts have also recently commented on the stock. BWS Financial reissued a "buy" rating and set a $45.00 target price (up previously from $40.00) on shares of TriMas in a research note on Wednesday, July 30th. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st.

TriMas Stock Down 0.5%

NASDAQ TRS traded down $0.20 during trading hours on Thursday, reaching $36.77. 397,269 shares of the company traded hands, compared to its average volume of 541,169. The stock has a market capitalization of $1.49 billion, a PE ratio of 40.41 and a beta of 0.66. TriMas has a 12 month low of $19.33 and a 12 month high of $37.49. The company has a 50 day moving average of $30.89 and a two-hundred day moving average of $26.06. The company has a current ratio of 2.59, a quick ratio of 1.44 and a debt-to-equity ratio of 0.59.

Hedge Funds Weigh In On TriMas

Several institutional investors and hedge funds have recently modified their holdings of TRS. Bank of America Corp DE boosted its holdings in shares of TriMas by 0.3% in the 2nd quarter. Bank of America Corp DE now owns 3,660,001 shares of the industrial products company's stock valued at $104,713,000 after buying an additional 9,602 shares during the last quarter. Pzena Investment Management LLC boosted its holdings in shares of TriMas by 2.0% in the 2nd quarter. Pzena Investment Management LLC now owns 2,177,761 shares of the industrial products company's stock valued at $62,306,000 after buying an additional 42,207 shares during the last quarter. Medina Value Partners LLC boosted its holdings in shares of TriMas by 2.9% in the 4th quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company's stock valued at $25,448,000 after buying an additional 28,851 shares during the last quarter. Irenic Capital Management LP acquired a new stake in shares of TriMas in the 1st quarter valued at approximately $19,997,000. Finally, Advisory Research Inc. boosted its holdings in shares of TriMas by 41.2% in the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock valued at $18,543,000 after buying an additional 220,000 shares during the last quarter. 99.42% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at TriMas

In related news, Director Adrianne Shapira purchased 4,000 shares of the stock in a transaction dated Thursday, June 5th. The stock was bought at an average cost of $25.82 per share, with a total value of $103,280.00. Following the purchase, the director directly owned 8,476 shares in the company, valued at $218,850.32. The trade was a 89.37% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Shawn Sedaghat acquired 72,937 shares of the firm's stock in a transaction that occurred on Thursday, May 22nd. The stock was acquired at an average price of $26.16 per share, with a total value of $1,908,031.92. Following the completion of the transaction, the director directly owned 1,883,758 shares in the company, valued at $49,279,109.28. This trade represents a 4.03% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders bought 848,232 shares of company stock valued at $21,644,995. 14.20% of the stock is currently owned by company insiders.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, August 12th. Stockholders of record on Tuesday, August 5th were paid a $0.04 dividend. The ex-dividend date of this dividend was Tuesday, August 5th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.4%. TriMas's dividend payout ratio is 17.58%.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.